These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14762606)

  • 21. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Task-based profile of vocal intensity decline in Parkinson's disease.
    Rosen KM; Kent RD; Duffy JR
    Folia Phoniatr Logop; 2005; 57(1):28-37. PubMed ID: 15655339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Language production in Parkinson's disease: acoustic and linguistic considerations.
    Illes J; Metter EJ; Hanson WR; Iritani S
    Brain Lang; 1988 Jan; 33(1):146-60. PubMed ID: 3342316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
    Pell MD; Cheang HS; Leonard CL
    Brain Lang; 2006 May; 97(2):123-34. PubMed ID: 16226803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cepstral analysis of hypokinetic and ataxic voices: correlations with perceptual and other acoustic measures.
    Jannetts S; Lowit A
    J Voice; 2014 Nov; 28(6):673-80. PubMed ID: 24836365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vocal acoustic characteristics of patients with Parkinson's disease.
    Tanaka Y; Nishio M; Niimi S
    Folia Phoniatr Logop; 2011; 63(5):223-30. PubMed ID: 21212679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardization of acoustic measures for normal voice patterns.
    Naufel de Felippe AC; Grillo MH; Grechi TH
    Braz J Otorhinolaryngol; 2006; 72(5):659-64. PubMed ID: 17221059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Methodology to Differentiate Parkinson's Disease and Aging Speech Based on Glottal Flow Acoustic Analysis.
    Gómez-Rodellar A; Palacios-Alonso D; Ferrández Vicente JM; Mekyska J; Álvarez-Marquina A; Gómez-Vilda P
    Int J Neural Syst; 2020 Oct; 30(10):2050058. PubMed ID: 32880202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
    Ghio A; Robert D; Grigoli C; Mas M; Delooze C; Mercier C; Viallet F
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(2):63-70. PubMed ID: 26521344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mean fundamental frequency in connected speech and sustained vowel with and without a sentence-frame.
    Iwarsson J; Hollen Nielsen R; Næs J
    Logoped Phoniatr Vocol; 2020 Jul; 45(2):91-96. PubMed ID: 31407616
    [No Abstract]   [Full Text] [Related]  

  • 32. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson's disease.
    Yang S; Wang F; Yang L; Xu F; Luo M; Chen X; Feng X; Zou X
    Sci Rep; 2020 Jul; 10(1):11776. PubMed ID: 32678256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity and fundamental frequency control in tracheoesophageal voice.
    Schindler A; Canale A; Cavalot AL; Albera R; Capaccio P; Ottaviani F; Schindler O
    Acta Otorhinolaryngol Ital; 2005 Aug; 25(4):240-4. PubMed ID: 16482982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysarthria and Quality of Life in neurologically healthy elderly and patients with Parkinson's disease.
    Lirani-Silva C; Mourão LF; Gobbi LT
    Codas; 2015; 27(3):248-54. PubMed ID: 26222941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speech production in Parkinson's disease: II. Acoustic and electropalatographic investigation of sentence, word and segment durations.
    McAuliffe MJ; Ward EC; Murdoch BE
    Clin Linguist Phon; 2006; 20(1):19-33. PubMed ID: 16393796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Speech production and sensory impairment in mild Parkinson's disease.
    Chen YW; Watson PJ
    J Acoust Soc Am; 2017 May; 141(5):3030. PubMed ID: 28599574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.